Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
04 April 1994Website:
http://www.tenaxthera.comNext earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 17:56:22 GMTDividend
Analysts recommendations
Institutional Ownership
TENX Latest News
Tenax Therapeutics (NASDAQ: TENX ) stock is falling hard on Thursday after the pharmaceutical company announced details for a public offering of its shares. That public offering has Tenax Therapeutics selling 1.6 million units.
Shares of pharmaceutical specialist Tenax Therapeutics (NASDAD: TENX ) are skyrocketing on Monday amid encouraging regulatory news. More specifically, with a focus on addressing cardiovascular and pulmonary diseases with high unmet medical need, Tenax has received clearance for its investigational new drug (IND) application for its pulmonary hypertension therapeutic.
Shares of Tenax Therapeutics surged over 300% after it announced the US Food and Drug Administration has reviewed and cleared its Investigational New Drug (IND) application for its hypertension candidate, TNX-103. The specialty pharmaceutical company said the FDA's enables it to proceed with the first of two Phase 3 studies for TNX-103 (oral Levosimendan) for the treatment of pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF).
What type of business is Tenax Therapeutics?
Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.
What sector is Tenax Therapeutics in?
Tenax Therapeutics is in the Healthcare sector
What industry is Tenax Therapeutics in?
Tenax Therapeutics is in the Biotechnology industry
What country is Tenax Therapeutics from?
Tenax Therapeutics is headquartered in United States
When did Tenax Therapeutics go public?
Tenax Therapeutics initial public offering (IPO) was on 04 April 1994
What is Tenax Therapeutics website?
https://www.tenaxthera.com
Is Tenax Therapeutics in the S&P 500?
No, Tenax Therapeutics is not included in the S&P 500 index
Is Tenax Therapeutics in the NASDAQ 100?
No, Tenax Therapeutics is not included in the NASDAQ 100 index
Is Tenax Therapeutics in the Dow Jones?
No, Tenax Therapeutics is not included in the Dow Jones index
When does Tenax Therapeutics report earnings?
The next expected earnings date for Tenax Therapeutics is 14 August 2024